Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1366
https://www.valueinhealthjournal.com/article/S1098-3015(16)32732-2/fulltext
Title :
Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32732-2&doi=10.1016/j.jval.2016.09.1366
First page :
A583
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1281